The Heartland Institute: Free Market Solutions

PolicyBot

PolicyBot is a search engine and database containing more than 24,000 studies and commentaries from more than 350 think tanks and advocacy groups. It’s free, fast, and comprehensive.

If you are conducting research on a particular topic, click on the plus (+) sign next to the topic in the list in the left-hand column of this page, then click on a subtopic. Titles, authors, publication date, reviews, and links to complete text will display for the 10 most-recent documents addressing that subtopic. Click on 2, 3, 4, etc. to see more documents.

If you are looking for an essay or report from a particular author or publisher, enter that information in the appropriate boxes below and then hit “search.” The search boxes can also be used to search by topic and subtopic. Problems or questions? Send an email to think@heartland.org.

If you come across what appears to be a “missing” or “empty” PolicyBot document, please let us know! Email us the URL or title of the document you’re trying to find, and we’ll get it fixed for you within minutes.

Search

Criteria

Keyword:
Author:
Publisher:
Added Since:
Document Number:
Topic:
Subtopic:

Results

Sort By: Date

85 article(s) found. Displaying article(s) 1 - 10.

1 2 3 4 5 ››

Debate Heats Up in Congress Over Biotech Drugs

Thomas Cheplick

Health Care News / The Heartland Institute / August 01, 2009

U.S. Sens. Charles Schumer (D-NY) and Susan Collins (R-ME) have introduced legislation that would grant biopharmaceutical firms a five-year window of patent ... (read more)

U.S. Gives FDA Power to Regulate Tobacco

Katie Emanuel

Health Care News / The Heartland Institute / August 01, 2009

Congress has approved a measure to regulate tobacco under the authority of the Food and Drug Administration for the first time in American history.The House ... (read more)

Michigan May Allow Suits Over FDA-Approved Drugs

Jillian Melchior

Health Care News / The Heartland Institute / July 01, 2009

A bill pending in the Michigan Senate would allow residents to sue drug companies for side effects, injury, or death despite the medication’s approval ... (read more)

FDA’s Critical Path Initiative Gets Mixed Results, Mixed Reviews

Jeff Emanuel

Health Care News / The Heartland Institute / March 01, 2009

Nine out of 10 Americans support the ideas behind the Food and Drug Administration’s Critical Path Initiative, a federal program designed to streamline ... (read more)

Grassley Seeks Probe of Unapproved Drugs

Katie Flanigan

Health Care News / The Heartland Institute / February 01, 2009

A longtime member of Congress is asking the U.S. Department of Health and Human Services to investigate nearly $200 million the government has spent on ... (read more)

FDA Is a Threat to Safety

Ryan Krause

Letter to the Editor / The Heartland Institute / July 02, 2008

The solution to FDA's recent failures is not more funding, but less, much less, as in none. ("FDA Still Searching for Salmonella Cause," July 2) FDA, by ... (read more)

FDA May Allow Pharmacists to Dispense Some Drugs Without a Doctor's Prescription

Jillian Melchior

Health Care News / The Heartland Institute / January 01, 2008

The U.S. Food and Drug Administration (FDA) is considering adopting a new drug classification that would allow some medications to be sold from behind the ... (read more)

FDA Should Not Regulate Tobacco: Poll

Karl Peterjohn

Health Care News / The Heartland Institute / January 01, 2008

A Zogby International telephone poll shows nearly two-thirds of Americans oppose the U.S. Food and Drug Administration (FDA) taking a role in regulating ... (read more)

Court Rules Against Potential FDA Reform

Marika Benko

Health Care News / The Heartland Institute / November 01, 2007

The Court of Appeals for the District of Columbia Circuit in early August ruled terminally ill patients do not have a constitutional right to use drugs ... (read more)

Experts Agree: FDA Reform Measure Is Flawed

Harriette Johnson

News Release / The Heartland Institute / September 21, 2007

(CHICAGO, September 21, 2007) Congress is in the eleventh hour for debate over the Food and Drug Administration Revitalization Act (FDARA), a funding bill ... (read more)